FSRH overweight, obesity, and contraception guideline
Covering evidence-based recommendations on the provision of contraception to women who are overweight or obese
NICE antenatal care guideline
Covering the organisation and delivery of antenatal care, including the involvement of partners
BSPID/EFP oral health and pregnancy guideline
A short, useful summary of key oral health recommendations for pregnant women from the British Society of Periodontology
PHE inadvertent vaccination in pregnancy guideline
This concise and useful summary covers monitoring of women vaccinated in pregnancy or shortly before conception
NICE heavy menstrual bleeding guideline
Includes recommendations on management and investigations on the causes of heavy menstrual bleeding, also covering history taking, diagnosis, and provision of information
Educational resources
Prescribing hormone replacement therapy (HRT) in postmenopausal women: a focus on Oestrogel® (estradiol) and Utrogestan® 100 mg (micronised progesterone)
This prescribing supplement has been commissioned and funded by Besins Healthcare (UK) Ltd and developed in partnership with Guidelines. Includes promotional information.
View prescribing and adverse event reporting information
OES/2021/001a October 2021
For healthcare professionals only.
Osteoporotic fracture guideline
This guideline was developed by a multidisciplinary expert panel: Cooper C et al with the support of an educational grant from UCB Pharma Ltd.
Women of child-bearing age with inflammatory rheumatic diseases guideline
This guideline was developed by a multidisciplinary expert panel: Giles I et al with the support of an educational grant from UCB Pharma Ltd.
The importance of the progestogenic component of hormone replacement therapy in women with a uterus
Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.
Uncomplicated recurrent UTI guideline
This guideline was developed by a multidisciplinary expert panel: Rees J et al with the support of a grant from Aspire Pharma Ltd.